» Articles » PMID: 37798772

A Mutant Methionyl-tRNA Synthetase-based Toolkit to Assess Induced-mesenchymal Stromal Cell Secretome in Mixed-culture Disease Models

Abstract

Background: Mesenchymal stromal cells (MSCs) have a dynamic secretome that plays a critical role in tissue repair and regeneration. However, studying the MSC secretome in mixed-culture disease models remains challenging. This study aimed to develop a mutant methionyl-tRNA synthetase-based toolkit (MetRS) to selectively profile secreted proteins from MSCs in mixed-culture systems and demonstrate its potential for investigating MSC responses to pathological stimulation.

Methods: We used CRISPR/Cas9 homology-directed repair to stably integrate MetRS into cells, enabling the incorporation of the non-canonical amino acid, azidonorleucine (ANL), and facilitating selective protein isolation using click chemistry. MetRS was integrated into both in H4 cells and induced pluripotent stem cells (iPSCs) for a series of proof-of-concept studies. Following iPSC differentiation into induced-MSCs, we validated their identity and co-cultured MetRS-expressing iMSCs with naïve or lipopolysaccharide (LPS)-treated THP-1 cells. We then profiled the iMSC secretome using antibody arrays.

Results: Our results showed successful integration of MetRS into targeted cells, allowing specific isolation of proteins from mixed-culture environments. We also demonstrated that the secretome of MetRS-expressing iMSCs can be differentiated from that of THP-1 cells in co-culture and is altered when co-cultured with LPS-treated THP-1 cells compared to naïve THP-1 cells.

Conclusions: The MetRS-based toolkit we have generated enables selective profiling of the MSC secretome in mixed-culture disease models. This approach has broad applications for examining not only MSC responses to models of pathological conditions, but any other cell type that can be differentiated from iPSCs. This can potentially reveal novel MSC-mediated repair mechanisms and advancing our understanding of tissue regeneration processes.

Citing Articles

Human iPSC-Derived MSCs Induce Neurotrophic Effects and Improve Metabolic Activity in Acute Neuronal Injury Models.

Kawatani K, Omana Suarez G, Perkerson 3rd R, Parent E, Nambara T, Knight J J Neurosci. 2024; 45(1).

PMID: 39496487 PMC: 11694398. DOI: 10.1523/JNEUROSCI.0606-24.2024.


Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage.

Gupta K, Perkerson 3rd R, Parsons T, Angom R, Amerna D, Burgess J Stem Cell Res Ther. 2024; 15(1):230.

PMID: 39075600 PMC: 11287895. DOI: 10.1186/s13287-024-03847-5.


Bioorthogonal non-canonical amino acid tagging to track transplanted human induced pluripotent stem cell-specific proteome.

Sridharan D, Dougherty J, Ahmed U, Sanghvi S, Alvi S, Park K Stem Cell Res Ther. 2024; 15(1):186.

PMID: 38926849 PMC: 11210150. DOI: 10.1186/s13287-024-03792-3.


Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells.

Singh A, Shetty D, Jacob A, Bayraktar S, Sinha S Front Cardiovasc Med. 2024; 11:1349548.

PMID: 38440211 PMC: 10910110. DOI: 10.3389/fcvm.2024.1349548.

References
1.
Kot M, Musial-Wysocka A, Lasota M, Ulman A, Majka M . Secretion, migration and adhesion as key processes in the therapeutic activity of mesenchymal stem cells. Acta Biochim Pol. 2019; 66(4):499-507. DOI: 10.18388/abp.2019_2895. View

2.
Behzadifard M, Aboutaleb N, Dolatshahi M, Khorramizadeh M, Mirshekari Jahangiri H, Kord Z . Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review. Neurochem Res. 2022; 48(5):1280-1292. DOI: 10.1007/s11064-022-03848-x. View

3.
Parekkadan B, Milwid J . Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010; 12:87-117. PMC: 3759519. DOI: 10.1146/annurev-bioeng-070909-105309. View

4.
Hoban D, Howard L, Dowd E . GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease. Neuroscience. 2015; 303:402-11. DOI: 10.1016/j.neuroscience.2015.07.014. View

5.
Su Y, Xu C, Cheng W, Zhao Y, Sui L, Zhao Y . Pretreated Mesenchymal Stem Cells and Their Secretome: Enhanced Immunotherapeutic Strategies. Int J Mol Sci. 2023; 24(2). PMC: 9864323. DOI: 10.3390/ijms24021277. View